GlassScriptPhysician profile
John V Montorello
NPI 1730202714
$773.46
in general payments reported to CMS, 2019-2025
14 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $109 · 2024: $49.91 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $245.04 | 2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $97.93 | 2019-2025 | Axonics |
| Valencia Technologies Corporation | $93.67 | 2025 | Ecoin Device Kit |
| Olympus America INC. | $56.48 | 2020-2025 | Itind System |
| Janssen Biotech, INC. | $55.31 | 2019-2020 | |
| Procept Biorobotics Corporation | $49.91 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $47.44 | 2019-2020 | |
| Agiliti Surgical, INC. | $29.39 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Ferring Pharmaceuticals INC. | $19.80 | 2019 | |
| Pfizer INC. | $17.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.19 | 2020 | |
| Travere Therapeutics, INC. | $16.77 | 2020 | |
| Coopersurgical, INC. | $15.68 | 2019 | |
| Dendreon Pharmaceuticals LLC | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Montorello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.